• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Lumisys turns profit despite dip in revenues

Article

Lumisys turns profit despite dip in revenuesRevenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000,

Lumisys turns profit despite dip in revenues

Revenues at Lumisys declined 24% during the company's second quarter. For the period (end-June), revenues were $5.4 million, compared with $7.2 million last year. The firm did post a profit of $62,000, however, compared with a net loss of $141,000 in 1997. Company executives believe the financial performance will improve going forward.

In other news, Lumisys has completed a beta test for its ACR-2000 CR system (PNN 6/98)

Related Videos
Emerging Research at SNMMI Examines 18F-flotufolastat in Managing Primary and Recurrent Prostate Cancer
Could Pluvicto Have a Role in Taxane-Naïve mCRPC?: An Interview with Oliver Sartor, MD
New SNMMI President Cathy Cutler, PhD, Discusses Current Challenges and Goals for Nuclear Medicine
Where the USPSTF Breast Cancer Screening Recommendations Fall Short: An Interview with Stacy Smith-Foley, MD
A Closer Look at MRI-Guided Transurethral Ultrasound Ablation for Intermediate Risk Prostate Cancer
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Related Content
© 2024 MJH Life Sciences

All rights reserved.